Horizon Pharma to Present at the 11th Annual JMP Securities Research Conference

(firmenpresse) - DEERFIELD, IL -- (Marketwire) -- 05/02/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the JMP Securities Research Conference on Monday, May 14, 2012 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern time) in San Francisco, CA. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at . A replay of the webcast will be available for 10 business days.

Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit .



Robert J. De Vaere
Executive Vice President and Chief Financial Officer


Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 02.05.2012 - 11:30 Uhr
Sprache: Deutsch
News-ID 141586
Anzahl Zeichen: 0

contact information:
Town:

DEERFIELD, IL

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 192 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Horizon Pharma to Present at the 11th Annual JMP Securities Research Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

Horizon Pharma (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Horizon Pharma plc Announces Board of Directors Following Closing of Acquisition ...

DUBLIN, IRELAND -- (Marketwired) -- 09/19/14 -- Horizon Pharma plc (NASDAQ: HZNP) today announced the appointment of its Board of Directors. The appointment of the Horizon Pharma plc Board follows the closing of the acquisition of Vidara Therapeutic ...

Horizon Pharma Completes Acquisition of Vidara Therapeutics International plc ...

DUBLIN, IRELAND -- (Marketwired) -- 09/19/14 -- Horizon Pharma (NASDAQ: HZNP) announced today it has completed the acquisition of Vidara Therapeutics International plc. In connection with the acquisition, Horizon and Vidara have combined with the re ...

Horizon Pharma Announces Stockholder Approval of Its Acquisition of Vidara Thera ...

DEERFIELD, IL -- (Marketwired) -- 09/18/14 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that at its Special Meeting of Stockholders held today, proposals related to Horizon's acquisition of Vidara Therapeutics International plc were a ...

Alle Meldungen von Horizon Pharma